Company Name: |
Sigma-Aldrich
|
Tel: |
021-61415566 800-8193336 |
Email: |
orderCN@merckgroup.com |
Products Intro: |
Product Name:DDRI-18 CAS:4402-18-0 Purity:>=98% (HPLC) Package:5MG Remarks:SML0710-5MG
|
Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
Tel: |
15076683720 |
Email: |
klq@cw-bio.com |
Products Intro: |
Product Name:DDRI-18 CAS:4402-18-0 Purity:大于98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
4008200310 |
Email: |
marketing@tsbiochem.com |
Products Intro: |
Product Name:DDRI-18 CAS:4402-18-0 Package:1mg/RMB 1300;5mg/RMB 3250;10mg/RMB 4750
|
Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
Tel: |
021-65675885 18964387627 |
Email: |
customer_service@efebio.com |
Products Intro: |
Product Name:DDRI-18 CAS:4402-18-0 Purity:95.00% Package:1mg;5mg;10mg
|
|
| 3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Basic information |
Product Name: | 3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine | Synonyms: | DDRI-18;3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine;DDRI18,DDRI 18;Benzenamine, 3,3'-[6,6'-bi-1H-benzimidazole]-2,2'-diylbis- | CAS: | 4402-18-0 | MF: | C26H20N6 | MW: | 416.48 | EINECS: | | Product Categories: | | Mol File: | 4402-18-0.mol | |
| 3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Chemical Properties |
Melting point | 297-299 °C | Boiling point | 835.8±75.0 °C(Predicted) | density | 1.382±0.06 g/cm3(Predicted) | storage temp. | 2-8°C | solubility | DMSO: soluble10mg/mL | form | powder | pka | 10.77±0.10(Predicted) | color | white to beige |
Hazard Codes | Xi | Risk Statements | 36/37/38 | Safety Statements | 26 | WGK Germany | 3 |
| 3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Usage And Synthesis |
Biochem/physiol Actions | DDRI-18 (DNA Damage Response Inhibitor-18) inhibits nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, and enhances the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin. |
| 3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Preparation Products And Raw materials |
|